My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

0.6320 +0.0462 (+7.89%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Jaguar Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Are There So Many Flight Delays Today? ↗

January 11, 2023

Travelers around the U.S. are wondering why there are so many flight delays today and the answer lies in what's happening with the FAA.

Via InvestorPlace

Dear JAGX Stock Fans, Mark Your Calendars for Jan. 12 ↗

January 11, 2023

Fans of Jaguar Health (JAGX) stock will want to keep an eye on the company tomorrow as it prepares for an investor webcast.

Via InvestorPlace

Why Lightning eMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket ↗

January 11, 2023

Gainers Broadwind, Inc. (NASDAQ: BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 11, 2023

It's time to start off the day with a breakdown of the biggest pre-market stock movers making the news on Wednesday morning!

Via InvestorPlace

Looking Into Jaguar Health's Return On Capital Employed ↗

December 23, 2022

Via Benzinga

Short Volatility Alert: Jaguar Health, Inc. ↗

July 05, 2022

On Friday, shares of Jaguar Health, Inc. (NASDAQ: JAGX) experienced volatile short activity. After the activity, the stock price went up +4.83% to $0.3082. The overall sentiment for JAGX has been...

Via Benzinga

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements ↗

January 10, 2023

Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space.

Via Benzinga

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session ↗

October 17, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.

Via Benzinga

Why Jaguar Health Stock Is Popping Off ↗

October 17, 2022

Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 12.9% to $0.16 during Monday's session after the company was granted orphan drug designation by the European Medicines agency for...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 17, 2022

Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 17, 2022

Good morning, investor! It's time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday!

Via InvestorPlace

Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket ↗

October 17, 2022

Gainers

Via Benzinga

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket ↗

September 15, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 30, 2022

Via Benzinga

Jaguar Health Seeks FDA Nod For Cholera Candidate Study ↗

August 30, 2022

Jaguar Health (NASDAQ: JAGX) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for its subsidiary Napo's NP-300 drug product candidate for the...

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 23, 2022

Via Benzinga

Looking Into Jaguar Health's Return On Capital Employed ↗

August 23, 2022

According to Benzinga Pro data, during Q2, Jaguar Health (NASDAQ:JAGX) posted sales of $2.92 million. Earnings were up 48.3%, but Jaguar Health still reported an overall loss of $9.39 million.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 22, 2022

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

Via Benzinga

Earnings Scheduled For August 22, 2022 ↗

August 22, 2022

Companies Reporting Before The Bell • Jaguar Health (NASDAQ:JAGX) is estimated to report quarterly loss at $0.22 per share on revenue of $3.10 million.

Via Benzinga

Jaguar Health's Earnings: A Preview ↗

August 19, 2022

Jaguar Health (NASDAQ:JAGX) is set to give its latest quarterly earnings report on Monday, 2022-08-22. Here's what investors need to know before the announcement. Analysts estimate that Jaguar Health...

Via Benzinga

Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea? ↗

June 27, 2022

San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 28, 2022

On Thursday, 108 companies set new 52-week lows.

Via Benzinga

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗

July 27, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

45 Stocks Moving In Tuesday's Mid-Day Session ↗

June 21, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.

Via Benzinga

67 Biggest Movers From Yesterday ↗

June 22, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

Via Benzinga

24 Stocks Moving in Tuesday's Pre-Market Session ↗

June 21, 2022

Gainers Valneva SE (NASDAQ: VALN) shares rose 83.6% to $25.18 in pre-market trading following Pfizer agreement to acquire an 8.1% stake.

Via Benzinga

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill ↗

June 15, 2022

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Via Benzinga

Two Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disorders ↗

June 09, 2022

Filament Health Corp. (OTCQB: FLHLF) and Jaguar Health, Inc. (NASDAQ: JAGX) have signed a letter of intent for a collaboration agreement.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.